Catheter Precision
VTAK
9 hedge funds and large institutions have $9.19M invested in Catheter Precision in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
10% less funds holding
Funds holding: 10 → 9 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
71% less capital invested
Capital invested by funds: $32.1M → $9.19M (-$22.9M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Alethea Capital Management
Mercer Island,
Washington
|
+$1.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$4.01M |
| 2 |
O
OrbiMed
New York
|
-$2.78M |
| 3 |
SCM
Sio Capital Management
New York
|
-$1.67M |
| 4 |
DM
Deerfield Management
New York
|
-$862K |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$613K |
VTAK Hedge Fund Activity: Q1 2019 in Review
9 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q1 2019, worth a combined $9.19M — down 71% from $32.1M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of VTAK and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Alethea Capital Management, opening a new position worth an estimated $1.67M. The largest seller was Millennium Management, exiting entirely with an estimated $4.01M sold.
- 9 institutional investors held Catheter Precision (VTAK) as of Q1 2019, down from 10 in Q4 2018.
- Funds reported $9.19M of Catheter Precision stock for Q1 2019, down 71% quarter-over-quarter.
- 1 fund opened new Catheter Precision positions in Q1 2019 and 2 closed out, a net change of -1 holder.
- The largest Catheter Precision buyer in Q1 2019 was Alethea Capital Management, an estimated $1.67M added.
- The largest Catheter Precision seller in Q1 2019 was Millennium Management, an estimated $4.01M sold.
Based on aggregated 13F filings for Q1 2019.